SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI)
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The study will involve administering the study drug as a single dose of study drug or
placebo. This study is designed to demonstrate the superiority of the experimental drug
versus placebo in adult patients with recurrent CDI.